Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Evogene ( (EVGN) ) has shared an update.
Evogene Ltd., a company involved in innovative solutions and strategic initiatives, has announced an organizational restructuring effective March 4, 2025. As part of this restructuring, Executive Vice President of Business Development, Mr. Eyal Ronen, will conclude his employment with the company. His responsibilities will be integrated into Evogene’s existing management structure, ensuring continuity in advancing business objectives and growth.
More about Evogene
YTD Price Performance: -21.65%
Average Trading Volume: 308,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $8.16M
For a thorough assessment of EVGN stock, go to TipRanks’ Stock Analysis page.
